170 related articles for article (PubMed ID: 30941643)
1. Prognosis of hormone-dependent breast cancer seems to be influenced by KEAP1, NRF2 and GSTM1 genetic polymorphisms.
Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L
Mol Biol Rep; 2019 Jun; 46(3):3213-3224. PubMed ID: 30941643
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
[TBL] [Abstract][Full Text] [Related]
3. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
Urpilainen E; Kangaskokko J; Puistola U; Karihtala P
Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
[TBL] [Abstract][Full Text] [Related]
4. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
Wong TF; Yoshinaga K; Monma Y; Ito K; Niikura H; Nagase S; Yamamoto M; Yaegashi N
Int J Gynecol Cancer; 2011 Nov; 21(8):1428-35. PubMed ID: 21897267
[TBL] [Abstract][Full Text] [Related]
5. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
6. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
7. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease.
Korytina GF; Akhmadishina LZ; Aznabaeva YG; Kochetova OV; Zagidullin NS; Kzhyshkowska JG; Zagidullin SZ; Viktorova TV
Gene; 2019 Apr; 692():102-112. PubMed ID: 30641209
[TBL] [Abstract][Full Text] [Related]
8.
Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
[TBL] [Abstract][Full Text] [Related]
9. GSTM1, GSTT1 and GSTP1 in patients with multiple breast cancers and breast cancer in association with another type of cancer.
Chirilă DN; Bălăcescu O; Popp R; Oprea A; Constantea NA; Vesa S; Ciuce C
Chirurgia (Bucur); 2014; 109(5):626-33. PubMed ID: 25375048
[TBL] [Abstract][Full Text] [Related]
10. [Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].
Xiao Y; Zhu X; Gu Y; Chen S; Liang L; Cao B
Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):241-250. PubMed ID: 29587953
[TBL] [Abstract][Full Text] [Related]
11. Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases.
Fontana X; Peyrottes I; Rossi C; Leblanc-Talent P; Ettore F; Namer M; Bussière F
Mutat Res; 1998 Jul; 403(1-2):45-53. PubMed ID: 9726005
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer.
Lizard-Nacol S; Coudert B; Colosetti P; Riedinger JM; Fargeot P; Brunet-Lecomte P
Breast Cancer Res; 1999; 1(1):81-7. PubMed ID: 11056682
[TBL] [Abstract][Full Text] [Related]
13. Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer.
Li S; Lang GT; Zhang YZ; Yu KD; Shao ZM; Zhang Q
Cancer Med; 2018 Sep; 7(9):4202-4207. PubMed ID: 30032483
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
Danilovic DLS; de Mello ES; Frazzato EST; Wakamatsu A; de Lima Jorge AA; Hoff AO; Marui S
Head Neck; 2018 Jun; 40(6):1271-1278. PubMed ID: 29469959
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer.
Dialyna IA; Arvanitis DA; Spandidos DA
Int J Mol Med; 2001 Jul; 8(1):79-87. PubMed ID: 11408954
[TBL] [Abstract][Full Text] [Related]
16. The role of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by PAHs in the calm Ruditapes philippinarum.
Wang H; Pan L; Si L; Miao J
Fish Shellfish Immunol; 2018 Sep; 80():325-334. PubMed ID: 29920381
[TBL] [Abstract][Full Text] [Related]
17. NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.
Lu K; Alcivar AL; Ma J; Foo TK; Zywea S; Mahdi A; Huo Y; Kensler TW; Gatza ML; Xia B
Cancer Res; 2017 Jun; 77(11):2881-2892. PubMed ID: 28416489
[TBL] [Abstract][Full Text] [Related]
18. GSTM1 and GSTT1 Genetic Polymorphisms and Breast Cancer Risk in Selected Filipino Cases.
Kalacas NA; Garcia JA; Sy Ortin T; Valdez Jr A; Fellizar A; Ramos MC; Albano PM
Asian Pac J Cancer Prev; 2019 Feb; 20(2):529-535. PubMed ID: 30803216
[TBL] [Abstract][Full Text] [Related]
19. GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
Chen T; Jinlin D; Wang F; Yuan Z; Xue J; Lu T; Huang W; Liu Y; Zhang Y
Cancer Lett; 2022 Jul; 538():215692. PubMed ID: 35487311
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
